The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women. A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.
visit:
https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600
The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women. A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.
visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600